Current role
Drug Manufacturers - Specialty & Generic · Healthcare
Chairman
2011-01-01–present
Jeffery S. Thompson
Chairman
Anika Therapeutics, Inc. (ANIK)Equibles does not estimate personal net worth.
Get an email with a short summary when Anika Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ANIK alertsAbout Jeffery S. Thompson
Jeffery S. Thompson is recorded as Chairman at Anika Therapeutics, Inc. (ANIK) since September 3, 2020. Anika Therapeutics, Inc. reported in an 8-K filed February 26, 2024 that Jeffery S. Thompson retired as Board of Directors. Anika Therapeutics, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Anika Therapeutics, Inc. includes Cheryl Blanchard (CEO and Board Member), Stephen (Steve) Griffin (CEO and Board Member), Stephen D. Griffin (CEO, CFO and Board Member) and 7 others.
“On February 24, 2024, Jeffery S. Thompson notified Anika Therapeutics, Inc. (the "Company") of his intention to retire from the Board of Directors (the "Board") after 13 years of dedicated service at the end of his current term.”
Affiliation history
-
Current
2020-09-03–present
-
2011-01-01–2024-02-26
Company network
Leadership on record at Anika Therapeutics, Inc.
- Cheryl Blanchard CEO, Board Member
- Stephen (Steve) Griffin CEO, Board Member
- Stephen D. Griffin CEO, CFO, Board Member
- Steve Griffin CEO, Board Member
- Cheryl R. Blanchard Chairman, Board Member
- John B. Henneman, III Chairman, Board Member
- Michael Levitz CFO
- Stephen Griffin CFO
- Anne Nunes COO
- David B. Colleran General Counsel